Concepts (188)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephrotic Syndrome | 5 | 2017 | 381 | 0.670 |
Why?
|
| Kidney Transplantation | 8 | 2021 | 4265 | 0.470 |
Why?
|
| Proteomics | 4 | 2008 | 3913 | 0.440 |
Why?
|
| Urogenital Abnormalities | 3 | 2021 | 255 | 0.430 |
Why?
|
| Urinary Tract | 3 | 2021 | 305 | 0.320 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 1936 | 0.290 |
Why?
|
| Organ Transplantation | 2 | 2023 | 1178 | 0.250 |
Why?
|
| Urine | 2 | 2008 | 362 | 0.250 |
Why?
|
| Drug Resistance | 2 | 2008 | 1600 | 0.240 |
Why?
|
| Review Literature as Topic | 1 | 2006 | 298 | 0.230 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2006 | 505 | 0.230 |
Why?
|
| Transplantation | 1 | 2005 | 221 | 0.230 |
Why?
|
| Albumins | 1 | 2006 | 577 | 0.210 |
Why?
|
| Transplantation Tolerance | 1 | 2008 | 633 | 0.210 |
Why?
|
| Central Nervous System Diseases | 2 | 2010 | 521 | 0.210 |
Why?
|
| Lymphoproliferative Disorders | 1 | 2006 | 529 | 0.200 |
Why?
|
| Peritoneal Dialysis | 1 | 2022 | 160 | 0.180 |
Why?
|
| Pedigree | 5 | 2020 | 4545 | 0.180 |
Why?
|
| Blood Proteins | 1 | 2006 | 1191 | 0.180 |
Why?
|
| Kidney Diseases | 2 | 2008 | 2100 | 0.170 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2000 | 65 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2008 | 1893 | 0.160 |
Why?
|
| Immune Tolerance | 1 | 2008 | 2323 | 0.160 |
Why?
|
| Renal Insufficiency | 2 | 2022 | 812 | 0.150 |
Why?
|
| Vesico-Ureteral Reflux | 2 | 2021 | 433 | 0.150 |
Why?
|
| Polycystic Kidney, Autosomal Dominant | 1 | 2019 | 166 | 0.150 |
Why?
|
| Nephrology | 1 | 2021 | 270 | 0.150 |
Why?
|
| Glomerulosclerosis, Focal Segmental | 1 | 2021 | 336 | 0.150 |
Why?
|
| Waiting Lists | 1 | 2023 | 779 | 0.150 |
Why?
|
| Nephrocalcinosis | 1 | 2017 | 51 | 0.140 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2020 | 257 | 0.140 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2017 | 25 | 0.140 |
Why?
|
| Oxalates | 1 | 2017 | 99 | 0.140 |
Why?
|
| Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
| Neutropenia | 1 | 2021 | 893 | 0.130 |
Why?
|
| Nephrolithiasis | 1 | 2017 | 117 | 0.130 |
Why?
|
| Child | 18 | 2023 | 80969 | 0.130 |
Why?
|
| Genetic Markers | 2 | 2017 | 2604 | 0.120 |
Why?
|
| Graft Rejection | 3 | 2021 | 4492 | 0.110 |
Why?
|
| Creatinine | 1 | 2020 | 1917 | 0.110 |
Why?
|
| Neurofibromatoses | 1 | 2018 | 303 | 0.110 |
Why?
|
| Proteinuria | 2 | 2007 | 610 | 0.110 |
Why?
|
| Forkhead Transcription Factors | 1 | 2020 | 1625 | 0.110 |
Why?
|
| Ectodermal Dysplasia | 1 | 2013 | 107 | 0.100 |
Why?
|
| Nephritis, Interstitial | 1 | 2014 | 158 | 0.100 |
Why?
|
| Steroids | 2 | 2008 | 938 | 0.100 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4123 | 0.100 |
Why?
|
| Mutation | 4 | 2020 | 30266 | 0.090 |
Why?
|
| Oseltamivir | 1 | 2011 | 75 | 0.090 |
Why?
|
| Reoperation | 1 | 2021 | 4342 | 0.090 |
Why?
|
| Child, Preschool | 10 | 2021 | 42684 | 0.080 |
Why?
|
| Repressor Proteins | 1 | 2020 | 2986 | 0.080 |
Why?
|
| Craniosynostoses | 1 | 2013 | 416 | 0.080 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2010 | 131 | 0.080 |
Why?
|
| Kidney | 5 | 2021 | 7057 | 0.080 |
Why?
|
| Lymphatic Irradiation | 1 | 2008 | 115 | 0.080 |
Why?
|
| Heredity | 2 | 2017 | 149 | 0.070 |
Why?
|
| BK Virus | 1 | 2008 | 120 | 0.070 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 452 | 0.070 |
Why?
|
| Lupus Nephritis | 1 | 2010 | 327 | 0.070 |
Why?
|
| Proteome | 2 | 2008 | 1891 | 0.070 |
Why?
|
| Epigenesis, Genetic | 1 | 2020 | 3836 | 0.070 |
Why?
|
| Lymphocyte Depletion | 1 | 2008 | 605 | 0.070 |
Why?
|
| Humans | 30 | 2023 | 768887 | 0.070 |
Why?
|
| Transplantation Chimera | 1 | 2008 | 594 | 0.060 |
Why?
|
| Polyomavirus Infections | 1 | 2008 | 192 | 0.060 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 869 | 0.060 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3447 | 0.060 |
Why?
|
| Ventricular Remodeling | 1 | 2013 | 1282 | 0.060 |
Why?
|
| Aortic Valve Stenosis | 1 | 2018 | 2034 | 0.060 |
Why?
|
| Tumor Virus Infections | 1 | 2008 | 437 | 0.060 |
Why?
|
| Liver Transplantation | 1 | 2017 | 2403 | 0.060 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 2297 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15889 | 0.060 |
Why?
|
| Immunosuppressive Agents | 2 | 2008 | 4207 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2019 | 18065 | 0.060 |
Why?
|
| Adolescent | 11 | 2019 | 89247 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2493 | 0.060 |
Why?
|
| Genetic Association Studies | 3 | 2018 | 2747 | 0.060 |
Why?
|
| Podocytes | 1 | 2007 | 403 | 0.050 |
Why?
|
| DNA-Binding Proteins | 1 | 2020 | 9618 | 0.050 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2006 | 696 | 0.050 |
Why?
|
| Bone and Bones | 1 | 2013 | 2589 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2010 | 1181 | 0.050 |
Why?
|
| Infant | 6 | 2020 | 36541 | 0.050 |
Why?
|
| Fatal Outcome | 1 | 2006 | 1836 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2014 | 2297 | 0.050 |
Why?
|
| Amphibian Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
| Multicenter Studies as Topic | 1 | 2006 | 1737 | 0.040 |
Why?
|
| Transcription Factors | 1 | 2020 | 12174 | 0.040 |
Why?
|
| Plasmapheresis | 1 | 2021 | 206 | 0.040 |
Why?
|
| Cryopreservation | 1 | 2006 | 733 | 0.040 |
Why?
|
| Bone Marrow Transplantation | 1 | 2008 | 2709 | 0.040 |
Why?
|
| Age of Onset | 2 | 2017 | 3346 | 0.040 |
Why?
|
| Myocardium | 1 | 2013 | 4790 | 0.040 |
Why?
|
| Renal Dialysis | 2 | 2022 | 1789 | 0.040 |
Why?
|
| Male | 15 | 2023 | 365249 | 0.040 |
Why?
|
| Virus Replication | 1 | 2008 | 2458 | 0.040 |
Why?
|
| Influenza, Human | 1 | 2011 | 1541 | 0.040 |
Why?
|
| Models, Animal | 1 | 2005 | 2123 | 0.040 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2021 | 631 | 0.040 |
Why?
|
| Phenotype | 4 | 2018 | 16735 | 0.040 |
Why?
|
| Larva | 1 | 2020 | 514 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2008 | 1959 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2005 | 2094 | 0.040 |
Why?
|
| Xenopus | 1 | 2020 | 711 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2011 | 3069 | 0.040 |
Why?
|
| Mass Spectrometry | 1 | 2005 | 2204 | 0.040 |
Why?
|
| Female | 14 | 2023 | 397464 | 0.040 |
Why?
|
| Hypertension | 1 | 2018 | 8615 | 0.040 |
Why?
|
| Prognosis | 4 | 2019 | 30044 | 0.040 |
Why?
|
| Hyperoxaluria | 1 | 2017 | 33 | 0.030 |
Why?
|
| Lymphoma | 1 | 2006 | 1900 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2006 | 1597 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2008 | 2192 | 0.030 |
Why?
|
| Carbon Monoxide | 1 | 2000 | 552 | 0.030 |
Why?
|
| Employment | 1 | 2023 | 1114 | 0.030 |
Why?
|
| Retrospective Studies | 6 | 2022 | 81892 | 0.030 |
Why?
|
| Radiography | 1 | 2006 | 6991 | 0.030 |
Why?
|
| Aorta, Abdominal | 1 | 2018 | 627 | 0.030 |
Why?
|
| Incidental Findings | 1 | 2019 | 697 | 0.030 |
Why?
|
| Infant, Newborn | 3 | 2022 | 26394 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 10778 | 0.030 |
Why?
|
| Social Class | 1 | 2023 | 2009 | 0.030 |
Why?
|
| Hemoglobins | 1 | 2000 | 1531 | 0.030 |
Why?
|
| Heterozygote | 1 | 2020 | 2798 | 0.030 |
Why?
|
| Graft Survival | 2 | 2019 | 3888 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2018 | 2280 | 0.030 |
Why?
|
| Abnormalities, Multiple | 1 | 2020 | 1423 | 0.030 |
Why?
|
| Pneumonia, Viral | 1 | 2011 | 3239 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2005 | 3048 | 0.030 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2013 | 474 | 0.020 |
Why?
|
| Nephrectomy | 1 | 2017 | 949 | 0.020 |
Why?
|
| Karyotyping | 1 | 2013 | 1177 | 0.020 |
Why?
|
| Granuloma | 1 | 2014 | 329 | 0.020 |
Why?
|
| Syndrome | 1 | 2018 | 3274 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2017 | 15471 | 0.020 |
Why?
|
| Proteins | 1 | 2005 | 6011 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2020 | 2121 | 0.020 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 13020 | 0.020 |
Why?
|
| Alleles | 1 | 2021 | 6901 | 0.020 |
Why?
|
| Plasma Exchange | 1 | 2010 | 159 | 0.020 |
Why?
|
| Family | 1 | 2020 | 3208 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2020 | 22294 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2019 | 1876 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 1 | 2006 | 9264 | 0.020 |
Why?
|
| Young Adult | 4 | 2017 | 60110 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2023 | 7860 | 0.020 |
Why?
|
| Confusion | 1 | 2010 | 278 | 0.020 |
Why?
|
| Length of Stay | 1 | 2022 | 6525 | 0.020 |
Why?
|
| Protein Binding | 1 | 2020 | 9344 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2017 | 2228 | 0.020 |
Why?
|
| Risk Assessment | 2 | 2019 | 24330 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2020 | 3982 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2013 | 1092 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2019 | 65485 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10115 | 0.020 |
Why?
|
| Risk Factors | 3 | 2020 | 74971 | 0.020 |
Why?
|
| Boston | 1 | 2019 | 9375 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2019 | 3590 | 0.020 |
Why?
|
| Triglycerides | 1 | 2013 | 2464 | 0.020 |
Why?
|
| Immunocompromised Host | 1 | 2011 | 865 | 0.020 |
Why?
|
| Animals | 3 | 2020 | 169408 | 0.020 |
Why?
|
| Cohort Studies | 2 | 2019 | 41800 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 749 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2020 | 14485 | 0.020 |
Why?
|
| Viremia | 1 | 2008 | 725 | 0.010 |
Why?
|
| Inflammation Mediators | 1 | 2013 | 1890 | 0.010 |
Why?
|
| Ultrasonography | 1 | 2017 | 6001 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 40266 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 14751 | 0.010 |
Why?
|
| Mice | 2 | 2020 | 82074 | 0.010 |
Why?
|
| Hospitalization | 1 | 2022 | 10845 | 0.010 |
Why?
|
| Autoantibodies | 1 | 2010 | 2126 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2013 | 3858 | 0.010 |
Why?
|
| Anemia | 1 | 2010 | 1516 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 15955 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2013 | 3941 | 0.010 |
Why?
|
| Disease Progression | 1 | 2017 | 13677 | 0.010 |
Why?
|
| Incidence | 1 | 2018 | 21545 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2013 | 5621 | 0.010 |
Why?
|
| Age Factors | 1 | 2013 | 18454 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2013 | 13054 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2017 | 20776 | 0.010 |
Why?
|
| Adult | 3 | 2017 | 223818 | 0.010 |
Why?
|
| United States | 1 | 2018 | 73180 | 0.010 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2013 | 12252 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 54950 | 0.000 |
Why?
|
Concepts
(188)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(62)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_